Transcript
Page 1: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

SKIN CARE IN ORGAN TRANSPLANT PATIENTS EUROPE

1 9 T H A N N U A L M E E T I N G

2019S E P T E M B E R , 2 6 T H – 2 8 T H

B A R C E L O N A , S PA I N

www.scopenetwork.org

Page 2: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

A C K N O W L E D G E M E N T S

M A I N S P O N S O R :

C O L L A B O R A T I O N S :

Passeig Vall d’Hebron, 119-129 – 08035 Barcelonawww.vallhebroncampus.com

@vallhebron

/vallhebroncampus

/company/vallhebron

Vall d’Hebron Barcelona Hospital Campus

Page 3: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Board members of SCOPEDeniz Seçkin, presidentMirjam Nägeli, executive secretaryBeata Imko, secretaryCarla Ferrándiz-Pulido, secretary and treasurer

Scientific committee for the SCOPE meeting in Barcelona 2019Catherine HarwoodCharlotte ProbyAlexandra Geusau

Local organizing committeeCarla Ferrándiz-Pulido

Lodging at Hotel Motel One Barcelona-Ciutadella.

Passeig de Pujades, 11-13, 08018 Barcelona

The meeting will take place ON THURSDAY at Escola Superior de Comerç Internacional ESCI-UPF, ROOM 4.1 (Passeig de Pujades 1; 4 minutes walking from the hotel)

The meeting will take place ON FRIDAY AND SATURDAY at Hospital Universitari Vall d’Hebron(travel by private bus). Área General, 10th floor.

SCOPE MEETING Barcelona26-28th September 2019

www.scopenetwork.org

Page 4: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Thursday 26th September 2019

BOARD MEETING 2 21:30 after dinner in the lobby Hotel Motel One Barcelona- Ciutadella

BOARD MEETING 1 15.00 - 16:00 in the lobby Hotel Motel One Barcelona-Ciutadella

Time Subject

16:00 – 17:00COFFEE at Escola Superior de Comerç Internaciona ESCI-UPF room 4.1 Passeig de Pujades 1

17:00 – 19:00 Workshops Chairs: Jan Nico Bouwes-Bavinck and Deniz Seçkin

17:00 – 17:05Deniz SeçkinIntroduction and Welcome

17:05 – 17:25 WS 1

Céleste LebbéSerological testing for HHV8 in OTR – should we be recommending it?University Department of Dermatology, Saint-Louis Hospital, INSERM U976, Paris, France

17:25 – 17:45 WS 2Charlotte ProbyUpdate Sun StudySchool of Medicine, University of Dundee, Scotland, UK

17:45 – 18:05 WS 3

Elsemieke PlasmeijerSkin cancer risk in SOTR treated with old versus new immunosuppressive drugsDept. of Dermatology, Erasmus MC, Rotterdam, The Netherlands

18:05 – 18:25 WS 4

Paul Massey Sequencing of Strategies for the Prevention of Skin Cancer in Solid Organ Transplant Recipients: A Delphi StudyBrigham and Women’s Hospital, Harvard Medical School, Boston, United States

18:25 – 18:55 Closing Discussions

19:30 - 21:00 WELCOME DINNER at HOTEL MOTEL ONE BARCELONA-CIUTADELLA.

www.scopenetwork.org

Page 5: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Friday 27th September 2019

Breakfast at Hotel Motel One Barcelona-Ciutadella.

Time Subject

07:45 Private Bus leaves from the Hotel to HUVH.

08:30– 08:45 Installation of the posters in 11th floor.Delivery of the presentations to technician 11th floor

S C I E N T I F I C M E E T I N G

08:45– 09:15Opening of the

meeting

Dr. Deniz SeçkinPresident of SCOPEBaskent University Faculty of Medicine, Ankara, Turkey

Dr. Antoni Roman BrotoDirector of Healthcare, HUVH

Dr. Vicente García-PatosChief of the Department of Dermatology, HUVH

Dr. Carla Ferrándiz-PulidoSecretary and local organizing committee SCOPEDermatology Department, HUVH

09:15 – 11:00 Free

communications IChairs: Charlotte Proby, Petter Giersvik(10 min presentation + 5 min discussion)

09:15– 09:30Abstract 1Research

R. Samuel HopkinsObservations from a High-Risk Non-Melanoma Skin Cancer Clinic in Oregon: Past Trends and Future DirectionsOregon Health & Science University, Portland, United States

09:30 – 09:45Abstract 2Research

Maren Buntinx

Skin disorders indicating peripheral vascular disease in organ transplant recipients: an observational study and inventory of risk factorsDepartment of Dermatology, Leiden University Medical Centre, Leiden, Netherlands

09:45 – 10:00Abstract 3Research

Emily RuizEvaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic marginsDepartment of Dermatology, Brigham and Women's Hospital, Boston, United States

10:00 – 10:15Abstract 4Research

Emoke RaczPatient-reported quality of life in solid organ transplant recipients with keratinocyte carcinomaDepartment of Dermatology; University of Groningen, University Medical Center Groningen, Groningen, Netherlands

www.scopenetwork.org

Page 6: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Friday 27th September 2019

10:15 – 10:30Abstract 5Research

John CarucciA Novel Analytic Solution to T-Cell Receptor Sequencing and Gene Expression Profiling Shows Transitory T Cell Phenotype Associated with High Risk Cutaneous Squamous Cell Carcinoma in Transplant Recipients.NYU-Langone Medical Center, New York, United States

10:30 – 10:45Abstract 6Research

Carla Ferrándiz-PulidoPosttransplant Merkel cell carcinoma: a multi-centre SCOPE-ITSCC case seriesDepartment of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain

10:45 – 11:00Abstract 7Research

Emilie DucrouxSirolimus for Secondary Prevention of Skin Cancer in Kidney Transplant Recipients: 5-Year ResultsHôpital Edouard Herriot, Lyon, France, Lyon, France

11:00 - 11:25 COFFEE BREAK AND POSTER VIEWING (11th floor)

11:30 – 12:00 Conference I Introduction by Dr. Alexandra Geusau

11:30 – 11:55 “Vaccine development strategies against cutaneous HPV infections”Dr Christina SchellenbacherLaboratory of Viral Oncology, Department of Dermatology, Medical University of Vienna, Vienna, Austria.

12:00 – 13:30 Free

communications II

Chairs: Sarah Arron, Beata Imko(10 min presentation + 5 min discussion)

12:00 – 12:15

Abstract 8Research

Alexandra GeusauIdentification of MicroRNA as a Tumour Marker for cutaneous squamous cell carcinomaDepartment of Dermatology, Medical University of Vienna, Vienna, Austria

12:15 – 12:30

Abstract 9Research

Carlos González-CruzCutaneous graft versus host disease: clinical experience in a third-level university pediatric hospitalDepartment of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain

12:30 – 12:45 Abstract 10Research

Charlotte ProbyTranscriptome-based classification of cutaneous squamous cell carcinoma predicts metastatic riskSchool of Medicine, University of Dundee, Scotland, UK

www.scopenetwork.org

Page 7: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Friday 27th September 2019

12:45 – 13:00Abstract 11

Research

Verónica RuizNon-melanoma skin cancer and infectious skin lesions incidence after transplantation: initial experience in a Spanish tertiary centerHospital de la Santa Creu i Sant Pau, Barcelona, Spain

13:00 – 13:15Abstract 12

Research

Edit OlaszWhat is the buzz about sunscreens in the US?Medical College of Wisconsin, Milwaukee, United States

13:15 – 13:30Abstract 13

Research

Mariano SuppaPotential of non-invasive skin imaging in OTRs managementDepartment of Dermatology - Hôpital Erasme - Université Libre de Bruxelles

13:30 – 14:25 LUNCH and POSTER VIEWING (11th floor)

14:30 – 15:30What is your diagnosis?

Chairs: Catherine Harwood, Walmar Roncalli, Manisha Loss(7 min case presentation + 8 min discussion)

14:30 – 14: 45Clinical Case 1

Marta Velasco GuidonetRash and abnormal liver function tests in a liver transplant recipientHospital Universitari Vall d’Hebron, Barcelona, Spain

14: 45 – 15:00 Clinical Case 2

Víctor Cabezas-CalderónMultiple violaceous nodules in the forearm of a kidney transplant recipientHospital Universitari Vall d’Hebron, Barcelona, Spain

15:00 – 15:15 Clinical Case 3Tom StaskoRefractory skin lesions in a teenage renal transplant recipient.The University of Oklahoma Health Sciences Center, USA

15:15 – 15:30 Clinical Case 4

José Manuel MascaróCystic lesions in the eyebrow of a renal transplant patientHospital Clínic and Barcelona University Medical School. Barcelona, Spain

www.scopenetwork.org

15:30 - 16:00 Conference II Introduction by Dr. Carla Ferrándiz-Pulido

15:30 – 15:55“Epigenetics and skin cancer”Dr. Manel EstellerDirector of Instituto de Investigación contra la Leucemia Josep Carreras

16:30 Private bus leaves from HVH to Hotel

18:00 – 20:00 Scientific interactive program in small groups

20:30 – 22:30 NETWORKING DINNER AT “RESTAURANT BANANAS”

Page 8: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Saturday 28th September 2019

Breakfast at Hotel Motel One Barcelona-Ciutadella.

Time Subject Speaker and title

08:00 Private Bus leaves from the Hotel to HUVH.

S C I E N T I F I C M E E T I N G

09:00 – 10:30Free

communications III

Chairs: Chrysalyne Schmults, Alexandra Geusau

(10 min presentation + 5 min discussion)

09:00 – 09:15Abstract 14

Research

Carlos González-CruzManagement of Kaposi Sarcoma in solid organ transplant recipientsHospital Universitari Vall d’Hebron, Barcelona, Spain

09:15 – 09:30Abstract 15

Research

Catherine HarwoodSPOT Study: SCC Prevention in Organ transplant recipients with Topical treatmentBarts and the London Queen Mary’s University of London, UK

09:30 – 09:45Abstract 16

Research

Edit OlaszMicroneedle-assisted 5-fluorouracil treatment of squamous cell carcinoma in situMedical College of Wisconsin, Milwaukee, United States

09:45 – 10:00Abstract 17

Research

Emily RuizBaseline and longitudinal radiologic imaging in high-risk cutaneous squamous cell carcinomas diagnose poor outcomes not identified on clinical examinationBrigham and Women's Hospital, Boston, United States

10:00 – 10:15Abstract 18

Research

Mirjam NaegeliCheckpoint inhibitors in solid organ transplant recipients (sOTR): Zurich's experienceUniversity Hosptial of Zurich, Zurich, Switzerland

10:15 – 10:30Abstract 19

Research

Christina ChungThe Burden of Cutaneous Disease in Organ Transplant Recipients of ColorMontgomery Dermatology, Lankenau Institute for Medical Research, King of Prussia, United States

10:30 – 10:55 COFFEE BREAK AND POSTER VIEWING (11th floor)

www.scopenetwork.org

Page 9: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

Saturday 28th September 2019

11:00 – 11:30 Conference III Introduction by Dr Mirjam Nägeli

11:00 – 11:25 “The Role of the Tumor Microenvironment in Skin Cancer”.Prof. Dr. Oscar ColegioChair of Dermatology & Professor of Oncology at Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

11:30 – 13:00How would you

treat?

Tumour Board: John Carruci, Jan Nico Bouwes- Bavinck, Tom Stasko, Céleste Lebbé(7 min case presentation + 8 min discussion)

11:30 – 11:45Clinical Case 1

Carla Ferrándiz-PulidoRecurrent squamous cell carcinoma of the scalp with lymphovascular invasion in a transplant recipient. Hospital Universitari Vall d’Hebron, Barcelona, Spain

11:45 – 12:00 Clinical Case 2

Ana Lilia Ruelas VillavicencioSquamous Intraepithelial Lesions and HPV Infection in the Immunosuppressed Patient National Institute of Medical Sciences and Nutrition. Mexico City, Mexico

12:00 -12:15 Clinical Case 3

Tom StaskoRecurrent pleomorphic dermal sarcoma of the scalp in a transplant recipient. The University of Oklahoma Health Sciences Center, USA

12:15 – 12:30 Clinical Case 4R. Samuel HopkinsTitle to be confirmedOregon Health & Science University, Portland, United States

12:30 – 12:45 Clinical Case 5Lilian BorikTumor progression beyond controlMedical University of Vienna, Vienna, Austria

12:45 – 13:00 Clinical Case 6

Andreas MeiwesSide effect under systemic treatment of metastasized SCC - a case report University of Tuebingen, Germany

13:00 – 13:55 LUNCH and POSTER VIEWING (11th floor)

www.scopenetwork.org

Page 10: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

www.scopenetwork.org

Saturday 28th September 2019

14:00 – 15:15Free communications

IVChairs: Emilie Ducroux, Emily Ruiz(10 min presentation + 5 min discussion)

14:00 – 14:15Abstract 20

Research

Stella de JongPreliminary Results of the SCOPE-ITSCC metastases studyLeiden University Medical Centre, Leiden, The Netherlands

14:!5 – 14:30Abstract 21

Research

Álvaro Gómez-TomásSUNTRAC screening tool: evaluation of the risk prediction calculator for ultraviolet neoplasia after solid organ transplantation in a Spanish cohort.Hospital Universitari Vall d’Hebron, Barcelona, Spain

14:30 -14:45

Abstract 22Research

Oscar ColegioBelatacept Reduces Skin Cancer Risk in Kidney Transplant recipients.Roswell Park Comprehensive Cancer Center, Buffalo, NY

14:45 – 15:00Abstract 23Research

Elizabeth BillingsleyAddressing Behavioral Change with Patients to Enhance UV Protective Behaviors: The ABC interventionPenn State University College of Medicine Protection from, Hershey, United States

15:00 – 15:15Abstract 24

Research

Sarah ArronDevelopment of a prognostic gene expression profile test in cutaneous squamous cell carcinoma in patients with one or more high risk featuresUniversity of California San Francisco, San Francisco, CA

15:15 – 15:45Annual General AssemblyBoard of SCOPE

- Information about SCOPE meeting 2020- Voting for Board members SCOPE- Other items- Closing ceremony

16:00 Private bus leaves from HVH to Hotel Motel One Barcelona-Ciutadella

19:00 – 22:30 CLOSING DINNER at “BORN TO COOK BARCELONA”

E N D O F M E E T I N G

Page 11: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

P O S T E R S

1 Dorothea RitzelMedical University of Vienna, Department of Dermatology, Vienna, Austria

Melanoma in an Austrian cohort of organ transplant recipients

2 Ingrid López-LermaDepartment of Dermatology, Hospital Universitari Vall d’Hebron, Barcelona, Spain

Post-transplant lymphoproliferative disorder manifesting as a solitary erythematous indurated plaque on the leg

www.scopenetwork.org

Page 12: TH A N N U A L M E E T I N G SKIN CARE IN ORGAN TRANSPLANT ...€¦ · Belatacept Reduces Skin Cancer Risk in Kidney Transplant recipients. Roswell Park Comprehensive Cancer Center,

See you soon at the next SCOPE meeting 2020 in Bochum!

Photography by DerHexer

www.scopenetwork.org


Top Related